Jump Financial, LLC Verastem, Inc. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.06 - $2.1 $29,892 - $59,220	-28,200 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.05 - $3.2 $57,809 - $90,240	28,200 New	28,200 $58,000
Q3 2021 Nov 12, 2021	SELL	$2.54 - $4.07 $177,800 - $284,900	-70,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.57 - $4.85 $179,900 - $339,500	70,000 New	70,000 $285,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $960M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.